Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Covestro    1COV   DE0006062144

COVESTRO (1COV)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer sells 9.4 percent stake in Covestro for 1.2 billion euros

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/13/2017 | 08:24am CET
The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

FRANKFURT (Reuters) - German drugs and pesticides group Bayer (>> Bayer) has further reduced its holding in Covestro (>> Covestro) to 31.5 percent from 40.9 percent by selling 19 million shares in the plastics business for a total of 1.2 billion euros. (1.08 billion pounds)

FRANKFURT (Reuters) - German drugs and pesticides group Bayer (>> Bayer) has further reduced its holding in Covestro (>> Covestro) to 31.5 percent from 40.9 percent by selling 19 million shares in the plastics business for a total of 1.2 billion euros. (1.08 billion pounds)

It said on Wednesday that it placed the stock at 63.25 euros each, a 3.7 percent discount to Tuesday's closing share price, which DZ Bank analyst Peter Spengler said indicated healthy demand for the stock.

Bayer, which is trying to wrap up the $66 billion takeover of U.S. seeds giant Monsanto (>> Monsanto) by the end of the year, had announced the accelerated bookbuilding late on Tuesday, part of its plan to fully sever ties with Covestro over the medium-term.

It has agreed to hold off for 90 days on placing more shares in Covestro, which it spun off as a listed company two years ago. Bayer's pension trust separately holds 8.9 percent of Covestro.

Barclays (>> Barclays) and Citigroup (>> Citigroup) acted as joint bookrunners for the placement, which was aimed at institutional investors.

(Reporting by Maria Sheahan; Editing by Amrutha Gayathri)

Stocks treated in this article : Citigroup, Monsanto, Bayer, Barclays, Covestro
Valeurs citées dans l'article
ChangeLast1st jan.
BARCLAYS 4.40% 211 Delayed Quote.-0.49%
BAYER 0.01% 98.44 Delayed Quote.-5.36%
CITIGROUP -0.06% 76.97 Delayed Quote.2.76%
MONSANTO 0.66% 121 Delayed Quote.3.02%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COVESTRO
02:25pCOVESTRO AG : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
02/20COVESTRO : 4Q Net Profit More Than Quadruples on Higher Selling Prices
DJ
02/20INNOVATION AND SUSTAINABILITY AS GRO : Covestro continues its profitable growth ..
PU
02/19KBR : Awarded Multi-Year Engineering Services Contract for Covestro’s Nort..
AQ
02/19PREMIERE AT SIMAC : ATOM Lab to present fully-automated shoe manufacturing: Bond..
PU
02/19COVESTRO : Disclosure according to Art. 2 (3) of Commission Delegated
EQ
02/15COVESTRO AG : annual earnings release
02/12COVESTRO : Disclosure according to Art. 2 (3) of Commission Delegated
EQ
02/09COVESTRO AT THE VDI CONGRESS "PLASTI : Concepts for e-mobility and autonomous dr..
PU
02/08FOCUS ON CHEMICAL-RESISTANT AND FLAM : Material partner of the medical equipment..
PU
More news
News from SeekingAlpha
02/01BASF shuts down Louisiana TDI plant as raw material supply disrupted 
01/11Bayer sells 10.4% stake in Covestro, raising ?1.8B 
2017Covestro AG 2017 Q3 - Results - Earnings Call Slides 
2017COVESTRO HAS A LUXURY PROBLEM : Are Special Dividends Around The Corner? 
2017Covestro AG (CVVTF) Investor Presentation - Slideshow 
Financials (€)
Sales 2018 14 447 M
EBIT 2018 2 637 M
Net income 2018 1 708 M
Debt 2018 663 M
Yield 2018 2,70%
P/E ratio 2018 10,38
P/E ratio 2019 10,60
EV / Sales 2018 1,36x
EV / Sales 2019 1,29x
Capitalization 19 039 M
Chart COVESTRO
Duration : Period :
Covestro Technical Analysis Chart | 1COV | DE0006062144 | 4-Traders
Technical analysis trends COVESTRO
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 103 €
Spread / Average Target 10,0%
EPS Revisions
Managers
NameTitle
Patrick Webster Thomas Chief Executive & Financial Officer
Richard Pott Chairman-Supervisory Board
Klaus Schäfer Chief Technology Officer
Petra Kronen Vice Chairman-Supervisory Board
Thomas Fischer Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
COVESTRO9.29%23 353
LG CHEM LTD--.--%24 428
FORMOSA PLASTICS CORPORATION--.--%22 634
FORMOSA CHEMICALS & FIBRE CORPORATION--.--%21 942
LOTTE CHEMICAL CORP--.--%13 998
HENGYI PETROCHEMICAL CO LTD--.--%6 749